Book a demo
Log In


Radioactive materials open up new pathways in patient treatment and medication


Radiopharmaceuticals are medications and treatments created using radioactive and nuclear isotopes. Radiopharmaceuticals can be designed to target certain organs or tissues in the body, which can improve the accuracy of diagnosis and treatment. These pharmaceuticals can allow for more precise radiation therapy with fewer side effects. Typically, radiopharmaceuticals are used to treat various medical conditions, including cancer, heart disease, and neurological disorders.

Radiopharmaceuticals can be also used for diagnostic services, where specialized imaging equipment, such as gamma cameras or positron emission tomography (PET) scanners are used to obtain detailed information about the structures and functions of organs and tissues.

Radiopharmaceuticals have gained traction recently, as they provide a non-invasive method of diagnosing and monitoring diseases, and, more recently, standards in handling and refining isotopes have seen improvements. More recent studies have also shown that radiopharmaceuticals typically have a short half-life, indicating a quick decay and thus not remaining in the body for an extended period of time, reducing the risk of long-term side effects.

Note: Additional sections (such as market sizing, detailed overview, and incumbents) can be provided on request.

See details

Market Mapping


The Disruptors

Funding History

Notable Investors

Funding data are powered by Crunchbase
Click here to learn more
Book a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.